Table 7

Long-term Trend Data (infusion for over a month) 9 Patients

% Predicted

% Predicted

% Predicted

% Predicted

% Predicted

Patient

FVC (L)

FEV 1 (L)

PEF (L/S)

FEF 25–75 (L/S)

FEF 75–85 (L/S)

Sex

Age

Mos.

# IVs Per pt.

Pre

Post

%

Pre

Post

%

Pre

Post

%

Pre

Post

%

Pre

Post

%

B, M.

F

57

9.5

11

73

97

33%

56

78

39%

89

109

22%

26

41

58%

29

40

38%

B, C

M

31

2.3

8

34

97

185%

39

69

77%

30

53

77%

17

45

165%

13

52

300%

D, K

F

16

5.3

11

119

143

20%

94

96

2%

95

134

41%

54

37

-31%

Not done

G, W.

M

74

3.5

4

48

67

40%

25

57

128%

16

93

481%

11

34

209%

38

54

42%

G, L.

F

63

3

4

50

82

64%

36

65

81%

51

56

10%

17

35

106%

21

36

71%

H, K.

F

55

5.3

11

61

105

72%

41

97

137%

56

120

114%

18

38

111%

20

43

115%

O, M.

F

48

19

4

72

90

25%

63

98

56%

60

88

47%

42

114

171%

42

145

245%

S, L.

F

64

10

9

61

86

41%

41

64

56%

73

113

55%

16

24

50%

27

22

-19%

S, W.

M

44

16

13

45

98

118%

35

77

120%

34

98

188%

21

45

114%

31

46

48%

Average

53

12.58

9.25

60

95

59%

45

84

87%

56

105

88%

24

55

128%

30

64

113%

Ave. # IVs per patient per month

0.74

Average Overall Improvement

95%

Long Term

Results were measured as percentage improvement in the percentage predicted on the Knudsen scale

Shrader Nutrition Journal 2004 3:6   doi:10.1186/1475-2891-3-6